CHM 4.17% 1.2¢ chimeric therapeutics limited

please explain, page-21

  1. 1,573 Posts.
    evat,

    not a personal attack or a good try, it's just the way it is. CHM twisting the judges words to mean something completely what it isn't is not cool, particularly for shareholders that don't understand the definitions.

    Like I said, MMX has much larger issues at the moment
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.